Chynops Pharma Pregabalin Chynops Pharma Pregabalin

X

Find Radio Compass News for Pregabalin

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
114
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

USP

JP

0

Other Listed Suppliers

SERVICES
left grey arrow
right gray arrow
  • TABLET, EXTENDED RELEASE;ORAL - 165MG
  • TABLET, EXTENDED RELEASE;ORAL - 330MG
  • TABLET, EXTENDED RELEASE;ORAL - 82.5MG
  • CAPSULE;ORAL - 100MG
  • CAPSULE;ORAL - 150MG
  • CAPSULE;ORAL - 200MG
  • CAPSULE;ORAL - 225MG
  • CAPSULE;ORAL - 25MG
  • CAPSULE;ORAL - 300MG
  • CAPSULE;ORAL - 50MG
  • CAPSULE;ORAL - 75MG

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209883

FDA
24 Jan 2024

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/two-painkillers-tapentadol-and-pregabalin-may-go-off-otc-over-misuse/articleshow/105482448.cms

ECONOMIC TIMES
25 Nov 2023

https://www.ema.europa.eu/en/documents/overview/pregabalin-sandoz-gmbh-epar-summary-public_en.pdf

EMA
13 Jun 2023

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214496

FDA
01 Jun 2023

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215675

FDA
14 Sep 2022

https://www.expresspharma.in/us-fda-approves-venlafaxine-extended-release-tablets-and-pregabalin-extended-release-tablets-by-zydus/

EXPRESS PHARMA
06 Sep 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207883

FDA
01 Sep 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215577

FDA
26 Aug 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216197

FDA
18 Jul 2022

https://health.economictimes.indiatimes.com/news/pharma/lupin-receives-usfda-approval-to-market-generic-pregabalin-capsules/91376335

ET HEALTH
06 May 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091040

FDA
03 May 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215249

FDA
22 Mar 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212988

FDA
08 Mar 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212604

FDA
18 Feb 2022

https://www.livemint.com/companies/news/sun-pharma-lupin-recall-products-in-us-market-11642310935658.html

LIVEMINT
16 Jan 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211967

FDA
03 Nov 2021

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-6-2021-1633509984.pdf

FDA
06 Oct 2021

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213313

FDA
12 Jul 2021

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211687

FDA
06 Jul 2021

https://psnc.org.uk/our-news/june-2021-price-concessions-1st-update/

PSNC
18 Jun 2021

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213226

FDA
17 Apr 2021

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211948

FDA
16 Apr 2021

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211889

FDA
16 Apr 2021

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211593

FDA
16 Apr 2021

https://www.pharmacompass.com/pdf/news/health-canada-issues-recalls-of-pharmascience-s-pms-pregabalin-50mg-1608716099.pdf

HEALTH CANADA
17 Dec 2020

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211948

FDA
15 Sep 2020

https://pfe-pfizercom-d8-prod.s3.amazonaws.com/2020-08/Final-Pfizer-Statement-on-Lyrica-Patent-Infringment-in-Japan.pdf?VPN0TpvJqxlt4CHCfrrs85unLOGQHdcY

PRESS RELEASE
20 Aug 2020

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091025

FDA
16 Jul 2020

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213423

FDA
28 Mar 2020

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212865

FDA
26 Mar 2020

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211593

FDA
20 Feb 2020

https://uk.reuters.com/article/us-pfizer-results/pfizer-posts-9-fall-in-fourth-quarter-revenue-idUKKBN1ZR1AX

Saumya Joseph REUTERS
28 Jan 2020

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212280

FDA
13 Jan 2020

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210585

FDA
27 Dec 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206912

FDA
11 Oct 2019

https://www.fiercepharma.com/pharma/icer-lambasts-abbvie-s-humira-genentech-s-rituxan-and-more-for-unsupported-price-hikes

A.Weintraub FIERCE PHARMA
09 Oct 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210891

FDA
01 Oct 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091228

FDA
24 Sep 2019

https://endpts.com/once-touted-as-lyrica-rival-for-diabetic-nerve-pain-korean-biotechs-plasmid-product-implodes-in-phiii/

Amber Tong ENDPTS
23 Sep 2019

https://www.fiercepharma.com/pharma/pfizer-could-merge-off-patent-drug-business-mylan-and-analysts-already-like-sound-it

Angus Liu FIERCE PHARMA
30 Jul 2019

http://www.pharmafile.com/news/524948/fda-approves-nine-generic-versions-pfizers-lyrica

PHARMAFILE
25 Jul 2019

https://www.in-pharmatechnologist.com/Article/2019/07/23/First-generics-of-Lyrica-receive-FDA-approval

Vassia Barba IN-PHARMATECHNOLOGIST
25 Jul 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207623

FDA
24 Jul 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208677

FDA
24 Jul 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209357

FDA
24 Jul 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209664

FDA
24 Jul 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209743

FDA
24 Jul 2019

https://www.fiercepharma.com/pharma/lyrica-generics-roll-pfizer-finally-hits-patent-cliff-for-nerve-pain-and-fibromyalgia

Eric Sagonowsky FIERCE PHARMA
23 Jul 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211384

FDA
23 Jul 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203459

FDA
23 Jul 2019
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY